Snake venom coagulopathy: Use and abuse of blood products in the treatment of pit viper envenomation

https://doi.org/10.1016/S0196-0644(05)80845-5Get rights and content

Coagulopathies are commonly encountered in victims of pit viper envenomation. In the majority of patients these defects improve with administration of antivenin. However, blood products are often transfused based on arbitrary criteria and with significant risk to the patient. This article documents the effectiveness and risks of antivenin administration and the risks of blood product transfusion. We recommend that blood products not be used except for clearly defined clinical indications.

References (42)

  • Human antitoxin in prophylaxis and treatment of tetanus

    Med Lett

    (1965)
  • SpaiteDW et al.

    Skin testing: Implications in the management of pit viper envenomation

    Ann Emerg Med

    (1988)
  • ChristensenPA

    Snakebite and the use of antivenin in Southern Africa

    S Air Med J

    (1981)
  • WingertWA et al.

    Rattlesnake bites in Southern California and rationale for recommended treatment

    West J Med

    (1988)
  • DartRC et al.

    Snakebite coagulopathy

    Clin Haemosr Rev

    (1990)
  • RitterE et al.

    Successful treatment with antivenin of marked thrombocytopenia without significant coagulopathy following rattlesnake bite

    Ann Emerg Med

    (1987)
  • SimonTL et al.

    Envenomation coagulopathy in wounds from pit vipers

    N Engl J Med

    (1981)
  • JurkovichGJ et al.

    Complications of Crotalidae antivenin therapy

    J Trauma

    (1988)
  • Consensus Conference, Office of Medical Applications of Research, National Institutes of Health

    Perioperative red blood cell transfusion

    JAMA

    (1988)
  • TaswellHF et al.

    Hemolytic transfusion reactions: Frequency and clinical and laboratory aspects

  • PinedaAA et al.

    Hemolytic transfusion reaction: Recent experience in large blood bank

    Mayo Clin Proc

    (1978)

    • Cited by (32)

    • An antivenin resistant, IVIg-corticosteroids responsive viper induced thrombocytopenia

      2022, Toxicology Reports
      Citation Excerpt :

      VIT is thus a well-known complication which remains of unclear etiology in North America, and even less described in the European countries; such discrepancy can be due to both intrinsic differences among venoms and different antivenin treatments. The course of VIT is known to be extremely variable: rattlesnake VIT is known to usually improve immediately after AV administration [16,17], but with an incomplete and variable effect [18]; a retrospective review of all patients admitted for rattlesnake envenomation in California over a period of about 20 years concluded that usually an immediate antivenom treatment improves VIT in a dosage independent manner and that the clinical significance remains uncertain in absence of bleeding [11]. In preliminary studies, thrombocytopenia improved immediately also after Fab antivenom administration, but recurred, necessitating repeat dosing [19], posing the question of its efficacy in improving VIT.

    • Retrospective Documentation of a Confirmed White-Lipped Green Pit Viper (Trimeresurus albolabris Gray, 1842) Bite in the South-Central Hills of Nepal

      2019, Wilderness and Environmental Medicine
      Citation Excerpt :

      This has been reported previously in Hong Kong.22 FFP supplies clotting factors such as fibrinogens that can be activated by the circulating venom toxins and those toxins absorbed by the uptake of additional venom possibly sequestered at the bite site.50,51 A recently conducted clinical trial investigating envenomed patients with consumptive coagulopathy52 suggested that using FFP and antivenom together restored clotting factors more rapidly and reduced clotting time and the amount of antivenom required.

    • Benefits of using heterologous polyclonal antibodies and potential applications to new and undertreated infectious pathogens

      2016, Vaccine
      Citation Excerpt :

      Safety of snake antivenins has improved with antibody fractionation and modern processing. Whole IgG rattlesnake antivenin (e.g. Antivenin Crotalidae Polyvalent ACP) was associated with a 18–50% frequency of immediate and delayed reactions [77–83]. This was more than halved after the removal of Fc and implantation of modern purification methods (e.g. Crofab®) [63,67,84–93,65,94].

    • Wilderness medical society practice guidelines for the treatment of pitviper envenomations in the United States and Canada

      2015, Wilderness and Environmental Medicine
      Citation Excerpt :

      Blood product transfusion (including packed red blood cells, fresh frozen plasma, cryoprecipitate, and platelets) may help maintain normal hematocrit in the case of severe bleeding; however, unlike antivenom, transfusion does not reverse or improve coagulopathies. Therefore, antivenom should be given initially and considered the mainstay of therapy, with transfusions reserved for only severe life-threatening hemorrhage or anemia refractory to antivenom treatment.123 ( Recommendation grade: 1C)

    • Venomous Bites and Stings

      2013, Current Problems in Surgery

    • Venomous Snakebites in North America

      2012, Emergency Medicine: Clinical Essentials, SECOND EDITION
    View all citing articles on Scopus
    View full text
    Copyright © 1991 Published by Mosby, Inc.